T-cell Acute Lymphoblastic Lymphoma

Universal 4SCAR7U Targeting CD7-positive Malignancies

Targeted Immunotherapy After Myeloablative TBI-Based Conditioning & AlloHCT in CAYA With High Risk T-Cell ALL & Lymphoma

Novel Unedited Allo Cell Therapy For High Risk T-Cell Malignancies Using CD7-Specific Car T Cells

Cell Therapy for High Risk T-Cell Malignancies Using CD7-Specific CAR Expressed On Autologous T Cells

Autologous T-Cells Expressing a Second Generation CAR for Treatment of T-Cell Malignancies Expressing CD5 Antigen

Safety and Efficacy of ThisCART7 in Patients With Refractory or Relapsed T Cell Malignancies

Non-gene Edited Anti-CD7 CAR T Cells for Relapsed/Refractory T Cell Malignances

Multi-CAR T Cell Therapy Targeting CD7-positive Malignancies